Physician’s role in drug selection continues to decline - Ongoing shift in influence towards drug plan managers, new prescribers and consumers IMS Canada Recognizes Quebec Health Professionals for their Contribution to the Appropriate Use of Medicines Canadian Prescription Drug Sales Experience Slowest Growth in a Decade with 6.3 Percent Increase. Growth of brand-name companies hit by all-time high value of patent expiries in 2007 IMS Health Predicts 5 to 6 Percent Growth for Global Pharmaceutical Market in 2008, According to Annual Forecast

IMS named one of Montreal’s Top 15 Employers CompuScript, the country’s gold standard in measuring Canadian prescription activity, helps researchers understand drug utilization in Canada "Stimulant Use in New Brunswick", a poster authored by IMS, was presented at the 2007 CADTH Invitational Symposium – Informing Policy, Influencing Practice, Improving Health, held in April 2007 in Ottawa. Canada’s Rx Atlas, a first-of-its-kind, gives a comprehensive portrait of the more than $20 billion spent on pharmaceuticals in Canada.

Contact | Global Website Directory | Help/FAQ | Privacy | Search | Site Map
Copyright © 2008 IMS Health Incorporated. All rights reserved.